Sei Investments Co. Purchases 12,142 Shares of Humana Inc. (NYSE:HUM)

Sei Investments Co. lifted its stake in Humana Inc. (NYSE:HUM - Free Report) by 16.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 86,472 shares of the insurance provider's stock after acquiring an additional 12,142 shares during the period. Sei Investments Co. owned 0.07% of Humana worth $21,937,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Pzena Investment Management LLC increased its position in shares of Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the period. Boston Partners grew its holdings in Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after acquiring an additional 893,637 shares during the period. FMR LLC grew its holdings in Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after acquiring an additional 643,291 shares during the period. Retirement Systems of Alabama raised its position in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after acquiring an additional 192,801 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC acquired a new stake in Humana in the 3rd quarter valued at about $50,102,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Remove Ads

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.37% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on HUM shares. Cantor Fitzgerald reiterated a "neutral" rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Piper Sandler upped their price target on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. Finally, StockNews.com downgraded Humana from a "buy" rating to a "hold" rating in a report on Tuesday, March 18th. Eighteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $285.68.

Humana Stock Down 2.4 %

Shares of NYSE:HUM traded down $6.43 during midday trading on Friday, hitting $263.95. 967,907 shares of the stock were exchanged, compared to its average volume of 1,758,856. The company has a market capitalization of $31.86 billion, a PE ratio of 26.53, a P/E/G ratio of 2.05 and a beta of 0.57. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The business's fifty day simple moving average is $270.14 and its two-hundred day simple moving average is $273.49.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana's dividend payout ratio (DPR) is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.